0001415889-22-009708.txt : 20220916 0001415889-22-009708.hdr.sgml : 20220916 20220916161512 ACCESSION NUMBER: 0001415889-22-009708 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220915 FILED AS OF DATE: 20220916 DATE AS OF CHANGE: 20220916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heyman Tomas J. CENTRAL INDEX KEY: 0001814673 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 221248224 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 170 HARBOR WAY 3RD FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-09162022_040901.xml X0306 4 2022-09-15 0001840233 Xilio Therapeutics, Inc. XLO 0001814673 Heyman Tomas J. 828 WINTER STREET SUITE 300 WALTHAM MA 02451 true false false false Stock Option (right to buy) 3.15 2022-09-15 4 A 0 26400 0 A 2032-09-14 Common Stock 26400 26400 D The option award was granted on September 15, 2022 and will vest in three equal installments on September 15, 2023, September 15, 2024 and September 15, 2025, subject to the Reporting Person's continued service as a director of the Issuer through the applicable vesting date. /s/ Chris Frankenfield, Attorney-in-Fact 2022-09-15